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Abstract 
 
Phosphomevalonate kinase (PMK) catalyzes phosphoryl transfer from 
adenosine triphosphate (ATP) to mevalonate 5-phosphate (M5P) on the 
pathway for synthesizing cholesterol and other isoprenoids. To permit this 
reaction, its substrates must be brought proximal, which would result in a 
significant and repulsive buildup of negative charge. To facilitate this difficult 
task, PMK contains 17 arginines and eight lysines. However, the way in which 
this charge neutralization and binding is achieved, from a structural and 
dynamics perspective, is not known. More broadly, the role of arginine side-
chain dynamics in binding of charged substrates has not been experimentally 
defined for any protein to date. Herein we report a characterization of 
changes to the dynamical state of the arginine side chains in PMK due to 
binding of its highly charged substrates, ATP and M5P. These studies were 
facilitated by the use of arginine-selective labeling to eliminate spectral 
overlap. Model-free analysis indicated that while substrate binding has little 
effect on the arginine backbone dynamics, binding of either substrate leads to 
significant rigidification of the arginine side chains throughout the protein, 
even those that are >8 Å from the binding site. Such a global rigidification of 
arginine side chains is unprecedented and suggests that there are long-range 
electrostatic interactions of sufficient strength to restrict the motion of 
arginine side chains on the picosecond-to-nanosecond time scale. It will be 
interesting to see whether such effects are general for arginine residues in 
proteins that bind highly charged substrates, once additional studies of 
arginine side-chain dynamics are reported. 
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Studies of the dynamical properties of proteins using NMR 
spectroscopy is an emerging field that has largely been limited to 
backbone N−H or side-chain methyl motions. It is often but not always 
true that changes to the dynamic state of the backbone reflect 
changes in the side chains. The NMR techniques for quantifying fast-
time-scale motion involve measuring the longitudinal (R1) and 
transverse (R2) relaxation rates as well as the heteronuclear nuclear 
Overhauser effect (NOE) for each amino acid backbone N−H (or side-
chain C−H) bond vector in the protein.1-3,10 These values can then be 
used to calculate the generalized order parameter (S2), which is a 
measure of protein flexibility. 
We have recently reported on the ligand-induced structural and 
dynamical changes of human phosphomevalonate kinase (PMK).4 PMK 
is the fifth enzyme in the mevalonate pathway in humans and is 
involved in steroid biosynthesis.5,6 PMK catalyzes phosphoryl transfer 
from adenosine triphosphate (ATP) to mevalonate 5-phosphate (M5P) 
to form adenosine diphosphate (ADP) and mevalonate 5-diphosphate. 
To permit phosphoryl transfer, the substrates are brought close 
together, resulting in a significant and repulsive buildup of negative 
charge. To facilitate this difficult task, PMK contains 17 arginines 
(Figure 1) and eight lysines, many of them in the active site to help 
neutralize the negative charge on the phosphates. The most important 
arginines, on the basis of site-directed mutagenesis studies, are R18, 
R48, R73, R84, R110, R111, and R141.7,8 Here we describe the use of 
NMR dynamics methods to characterize changes in the mobility of 
arginine side chains upon ligand binding. NMR dynamics methods, 
which have recently been applied to arginine side chains,10,11,13 allow 
study of the role that arginine side chains play in ligand binding and 
catalysis. Our studies provide surprising insights into ligand effects on 
arginine side chains that are remote from the active site, perhaps due 
to long-range Coulombic attractions. 
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Figure 1. Ternary complex of human PMK, with M5P and ATP docked independently 
into the apo crystal structure (PDB entry 3CH4).9 After the substrates were docked, 
the structure was optimized using molecular dynamics (50 ps at 300 K). All of the 
arginines are shown, and those known to be important for substrate binding or 
catalysis are labeled. The interphosphate distance is 7 Å, so phosphate transfer 
requires additional domain movement. 
Since PMK is a rather large protein (24 kDa), in terms of NMR 
studies, samples were prepared with only arginines having the 15N 
label (Figure 2A). This allowed us to make sure that every arginine 
backbone residue was considered, without concern for signal overlap, 
along with the ε-N−H’s of the side chain. Other arginine side-chain 
N−H’s, though labeled, exchange too rapidly to be observed. Because 
PMK has significant resonance overlap in the backbone N−H region 
and also because of significant relaxation that precluded side-chain 
assignments via TOCSY experiments, only half of the arginine residues 
could be assigned. The assigned arginines are labeled accordingly on 
the spectra, and the rest of the arginine backbone N−H’s are labeled 
R-A through R-I. The ε-N−H’s of the arginine side chains are shown at 
the top of Figure 2A and expanded in Figure 2B. As these side-chain 
N−H’s could not be assigned to their respective backbone N−H’s, they 
have been labeled SC-1 through SC-13; furthermore, four of the 17 
residues are apparently exchange-broadened. 
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Figure 2. (A) 1H−15N HSQC spectrum of 15N-Arg-PMK, with backbone residues 
labeled. (B) Expansion of the arginine side-chain region, with assignment labels. 
Overlaid expansions in boxes show data for mutation-based assignments (mutated 
PMK in black). Spectra of a 500 μM PMK solution (20 mM potassium phosphate, 5 mM 
dithiothreitol, 10% D2O, 10% glycerol-d6) were recorded at 298 K using a 600 MHz 
Varian NMR system. 
To monitor arginine involvement in the binding of PMK’s 
substrates, chemical-shift titration experiments were performed 
(Figure S1 in the Supporting Information). Increasing amounts of M5P 
and MgADP were added to PMK, and the arginine backbone and side 
chains were monitored using 1H−15N HSQC spectra. The majority of 
the arginine N−H’s showed very small chemical shift changes, 
indicating little change in chemical environment for residues labeled 
SC-2 and SC-5−13. For residues labeled SC-1, -2, and -4, the 
chemical shifts were exchange-broadened, indicating some change in 
environment and motion due to binding of M5P (Figure S1C). This 
experiment was duplicated using MgADP (Figure S1D), monitoring 
chemical shift changes as before. Only SC-1, -2, and -4 showed large 
chemical shift changes, suggesting that they are involved in binding. 
Dynamics experiments were performed as before, where we 
showed that substrate-induced domain movement occurs in PMK.4 The 
longitudinal relaxation rates (R1) were generally the same for the 
backbone and side chains for each particular complex and agreed with 
previous results4 (Figure S2 and Table S1). The transverse relaxation 
rates (R2) of the backbone N−H’s also correlated with previous 
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studies.4 The side chains, however, showed a decrease in transverse 
relaxation rates relative to the backbone. This decrease in R2 values 
for the apo-PMK arginine side chains was significant (half relative to 
backbone). The decrease in R2 was small for the M5P/PMK complex, 
with the other two complexes showing an intermediate decrease. The 
1H−15N NOE values for the side chains varied from residue to residue, 
but this variability was consistent between complexes. 
As in previous studies,4 a model-free analysis2 was used to 
generate the generalized order parameter, S2. The S2 value is a 
measure of rigidity (where S2 = 1.0 indicates complete rigidity and S2 
= 0.0 complete fluidity) on the nanosecond-to-picosecond time scale 
for the bond of interest,1,2 in our case the arginine backbone and side-
chain N−H bond vectors. Model-free analysis can also differentiate 
between global and local motions. In our previous work on PMK, we 
showed that domain movement (global motion) was affected by ligand 
binding, with little attenuation of local motions. In the side-chain 
studies presented herein, it was observed that ligand binding causes 
the arginine ε-N−H’s to increase S2 on average from 0.47 in apo-PMK 
to 0.64−0.75 in the binary and ternary complexes (Figure 3). This 
leads to the conclusion that ligand binding causes arginine side chains 
to rigidify throughout the protein, even distal to the binding site, 
perhaps as a result of long-range Coulombic interactions with the 
substrates. The S2 values for the arginine backbones corresponded to 
our previous results4 on fully 15N labeled PMK, where we reported 
changes in τc due to domain motion, analogous to those in adenylate 
kinase (Table S1); the differences are attributed to different buffer 
conditions. Surprisingly, the backbone dynamics changes were 
minimal, in stark contrast to the side-chain effects. 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Journal of the American Chemical Society, Vol 132, No. 7 (February 24, 2010): pg. 2102-2103. DOI. This article is © 
American Chemical Society and permission has been granted for this version to appear in e-Publications@Marquette. 
American Chemical Society does not grant permission for this article to be further copied/distributed or hosted 
elsewhere without the express permission from American Chemical Society. 
7 
 
 
Figure 3. Generalized order parameters (S2 values) for all assigned and unassigned 
arginine backbone and side-chain ε-N−H’s, where blue refers to apo-PMK, red to the 
M5P/PMK complex, yellow to the MgADP/PMK complex, and green to the 
M5P/MgADP/PMK ternary complex. Using site-directed mutagenesis, we have 
tentatively assigned SC-2 and -3 as R84 and R111, with SC-5 likely being assigned as 
R130 and SC-12 probably being R141. Nearly all of the arginine side-chain residues 
undergo a significant increase in S2 (i.e., rigidification) upon binding to either ligand. 
While Arg84 and Arg111 are close to charged atoms on the substrate, Arg130 and 
Arg141 are >10 Å from charged atoms. 
It has been noted in studies of side-chain methyl groups that 
changes in the dynamic state of side chains may not be well-reflected 
in changes observed in the backbone.12,14 We also have observed quite 
large differences between the backbone and side-chain responses to 
substrate binding. Whether such dramatic differences between side-
chain and backbone dynamics changes are common in arginines (vs 
aliphatic side chains) and/or in interactions with highly charged 
substrates (multiple phosphate groups) cannot be concluded until 
more arginine side-chain dynamics studies on other proteins are 
reported. 
While it is possible that substrate binding simply causes a global 
rigidification of side chains in PMK, this seems unlikely. We propose 
that side chains rigidify because of Coulombic attraction from the 
highly charged substrate(s); in support of this hypothesis, the ADP-
induced S2 effect is abolished in high salt (Figure S8). This must be a 
long-range effect, since only four arginines are within 4 Å and only six 
arginines are within 8 Å, even though ∼10 arginine side chains rigidify 
(Figure 3). 
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In summary, we have shown that substrate binding to PMK 
causes arginine side chains to undergo a transition from a flexible to a 
rigid state. The magnitude and global nature of this effect is 
significant. Besides providing mechanistic insights, such studies 
facilitate docking by identifying flexible side chains. 
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